Pamela Frank, BSc, ND
Learn how critical micronutrients like chromium, magnesium, and zinc impact glucose metabolism, insulin sensitivity, and the prevention of chronic conditions like Type 2 diabetes.
Abstract
Micronutrient deficiencies play a crucial role in the pathogenesis of glucose dysregulation and insulin resistance. Chromium, magnesium, zinc, vanadium, B vitamins, and inositol each support key enzymatic and signaling pathways that regulate glucose uptake, insulin sensitivity, and energy metabolism. Deficiencies in these essential nutrients disrupt insulin-mediated glucose transport, impair β-cell function, and exacerbate oxidative stress and inflammation. Evidence indicates that correcting these deficiencies through targeted dietary or supplemental intervention may improve glycemic control, enhance insulin signaling, and reduce the risk of Type 2 diabetes and related metabolic disorders.
Introduction
Balanced glucose metabolism is fundamental to maintaining overall health, weight management, and reducing the risk of chronic disease, including Type 2 diabetes mellitus (T2DM), cardiovascular disease1,2, and cancer. Glucose homeostasis involves tightly regulated glucose uptake, storage, and utilization processes to maintain blood glucose levels within a physiological range. Dysregulation of these processes contributes to insulin resistance, hyperglycemia, and metabolic syndrome. Effectively balancing glucose mitigates systemic inflammation, oxidative stress, and vascular dysfunction, which are associated with poor metabolic health3.
Micronutrients, such as chromium, vanadium, certain B vitamins, magnesium, and zinc, are integral to the enzymatic and cellular pathways involved in glucose metabolism. These essential nutrients are cofactors for enzymes regulating insulin signaling, glucose uptake, and oxidative phosphorylation. Their roles in modulating insulin sensitivity, β-cell function, and mitochondrial efficiency are well-documented. Deficiencies in these micronutrients can impair glucose homeostasis and amplify the risk of metabolic disorders, highlighting the critical need for adequate micronutrient intake for metabolic health.
Key Steps Where Micronutrients are Involved in Insulin-Mediated Glucose Uptake
- Insulin binding to the insulin receptor activates receptor kinase activity.
- Autophosphorylation of the receptor leads to the recruitment of insulin receptor signaling proteins.
- Activation of PI3K/Akt signaling promotes GLUT-4 translocation to the plasma membrane.
- GLUT-4 facilitates glucose uptake into the cell.
- Protein Tyrosine Phosphatases (PTPs), such as PTP1B, regulate the intensity of the insulin signaling cascade by dephosphorylating key proteins like the insulin receptor and IRS proteins.
These cellular mechanisms, regulated by the insulin receptor, GLUT-4, and PTPs, work in concert to ensure that glucose is efficiently taken up by cells and stored or utilized for energy. Disruptions in any of these steps contribute to glucose dysregulation and are implicated in the pathogenesis of insulin resistance and diabetes4, 5, 6.
Chromium
Role in Glucose Metabolism
Chromium is an essential trace mineral pivotal in glucose metabolism. It enhances insulin signaling by improving insulin receptor kinase activity, which amplifies insulin’s downstream effects. Chromium also facilitates the translocation of glucose transporter-4 (GLUT-4) to the cell membrane, promoting efficient glucose uptake in peripheral tissues.
Mechanism of Action
The mechanism by which chromium exerts its effects involves potentiating insulin action. Chromium binds to chromodulin, a substance that amplifies insulin’s ability to bind to its receptor. This interaction enhances glucose uptake, reduces circulating blood glucose levels, and helps maintain glucose homeostasis.
Evidence for Chromium Use in Dysglycemia
Clinical evidence supports the role of chromium in glucose regulation. Studies have reached conflicting conclusions on the efficacy of chromium supplementation7. Some have demonstrated significant reductions in fasting blood glucose levels, glycosylated hemoglobin (HbA1c), and insulin resistance markers following chromium supplementation in diabetics.8,9,10
A 2024 study demonstrated that combined treatment with Chromium yeast (160 mcg) and Magnesium (200 mg) for 3 months was more effective than receiving Chromium or Magnesium alone and was associated with reduced inflammation and oxidative stress.11
Discrepancies between studies on the benefits of chromium supplementation may be due to differences in baseline insulin sensitivity (patients with insulin resistance respond better to chromium), the quantity of chromium administered, the study period, the sample size, and the type of diabetes mellitus.12
Food Sources and RDI
The recommended daily intake (RDI) for chromium is 30 mcg for adult males and 20 mcg for adult females. Half a cup of broccoli contains 11 mcg of chromium, and 3 ounces of beef contains two mcg. Other food sources include liver, eggs, chicken, oysters, spices, beans, peas, and lentils.
Therapeutic Dose and Safety
Chromium picolinate has been safely used in a small number of studies on adults at doses of 200-1000 mcg daily for up to 2 years. Most studies have used chromium doses ranging from 150-600 mcg in adults. The Food and Drug Administration (FDA) evaluation of the safety of chromium suggests that it is safe when used in doses of 200 mcg daily for an adult for up to 6 months.
Chromium is well-tolerated orally. The most common adverse effects include gastrointestinal irritation, headaches, insomnia, irritability, and mood changes.
Vanadium
Biological Activity and Role
Vanadium is a trace mineral known for its insulin-mimetic properties. By mimicking insulin action at the cellular level, vanadium enhances glucose uptake and promotes glycogen synthesis in peripheral tissues. These effects position vanadium as a potential therapeutic agent for improving glucose metabolism in individuals with insulin resistance or diabetes.
Mechanism of Action
Vanadium’s insulin-like effects are mediated by inhibiting protein tyrosine phosphatases (PTPs). This inhibition preserves the phosphorylation state of insulin receptor substrates, thereby sustaining insulin signaling pathways. The result is enhanced glucose transport and cell metabolic regulation, independent of endogenous insulin activity.
Evidence for Vanadium’s Benefit
Clinical studies investigating vanadium salts, such as vanadyl sulfate, have shown moderate improvements in fasting blood glucose and insulin sensitivity in diabetic individuals13,14. For instance, trials suggest a reduction in hyperglycemia without requiring concomitant insulin administration.
Food Sources and RDI
Vanadium is found in mushrooms, shellfish, black pepper, parsley, grains, grain products, and beverages such as beer and wine.
The recommended daily intake (RDI) for vanadium is 10 to 20 mcg. The average diet provides 6–18 mcg of vanadium.
Therapeutic Dose and Safety
Vanadium is safe when taken below the tolerable upper intake level (UL) of 1.8 mg daily. Higher doses may cause adverse gastrointestinal effects, including abdominal discomfort, diarrhea, flatulence, and nausea. High doses taken over a long period can cause kidney damage.
B Vitamins
Vitamin B6 (Pyridoxine)
Role in Glucose and Energy Metabolism
Vitamin B6 plays a crucial role in carbohydrate metabolism as a coenzyme for enzymes involved in glycogenolysis and gluconeogenesis.15,16 Pyridoxine-dependent enzymes facilitate the transamination and decarboxylation of amino acids, vital for maintaining blood glucose levels during fasting or metabolic stress.16
The active form of B6, pyridoxal-5-phosphate, works as a cofactor in approximately 200 reactions that regulate the metabolism of glucose, lipids, amino acids, DNA, and neurotransmitters.17
Furthermore, vitamin B6 supports neurotransmitter synthesis, which can influence appetite regulation and glucose homeostasis.
Evidence and Deficiency Implications
Deficiency in vitamin B6 has been linked to impaired glucose tolerance and increased risk of diabetes-related complications. Pyridoxine deficiency can disrupt homocysteine metabolism, leading to elevated homocysteine levels, a recognized risk factor for cardiovascular disease in diabetic patients. Studies also suggest adequate vitamin B6 levels may improve endothelial function and reduce oxidative stress in diabetes. Vitamin B6 may protect against diabetic complications through its action as a scavenger of Advanced Glycation End products (AGEs).17
Vitamin B6 deficiency is rare in developed countries but can lead to symptoms such as irritability, depression, and cognitive impairment.
Food Sources and RDI
Good food sources of vitamin B6 include poultry (such as chicken and turkey), fish (like salmon and tuna), and organ meats (such as liver). Other sources include spinach and avocados. For adults, the RDI is approximately 1.3-2.0 mg per day, with higher needs during pregnancy and lactation (1.9-2.0 mg).
Therapeutic Dose and Safety
Vitamin B6 is likely safe when used orally and appropriately in doses that do not exceed the tolerable upper intake level (UL) of 100 mg daily for adults. Long-term intake of high doses of vitamin B6 (500-1000 mg per day) is correlated with neuropathy.18,19
Side effects of vitamin B6 supplementation include abdominal pain, allergic reactions, headache, heartburn, loss of appetite, nausea, somnolence, and vomiting.
Inositol
Role in Glucose and Energy Metabolism
Inositol was formerly known as vitamin B8. More recently, it is considered a vitamin-like compound because it can be synthesized in the human body. It is a precursor for inositol phosphates and phosphoinositides, which play pivotal roles in insulin signal transduction. Myo-inositol and D-chiro-inositol are the two primary forms of inositol in glucose metabolism. They facilitate glucose uptake by enhancing insulin sensitivity and improving the efficiency of glucose transporter proteins (GLUTs).
Evidence and Deficiency Implications
Clinical trials have demonstrated that supplementation with myo-inositol and D-chiro-inositol improves insulin sensitivity, reduces fasting glucose levels, and enhances metabolic parameters in individuals with insulin resistance.20,21,22 Deficiency or altered inositol metabolism has been associated with impaired insulin signaling and increased risk of Type 2 Diabetes Mellitus. Inositol supplementation has also shown potential in mitigating diabetic neuropathy by supporting nerve function and reducing oxidative stress.
Food Sources and RDI
There is no officially established Recommended Dietary Intake (RDI) for inositol. Typical dietary intakes are estimated to range between 500 and 1,000 mg per day in the average diet. Rich food sources of inositol include fruits, particularly citrus fruits and cantaloupe, as well as whole grains, beans, and nuts. It is also found in smaller amounts in vegetables like Brussels sprouts and cabbage, and in animal-derived foods such as eggs and organ meats.
Therapeutic Dose and Safety
Inositol is typically used in doses of 1-4 grams daily in adults. Myo-inositol, 4 grams daily, has been used with apparent safety for up to 6 months.
Magnesium
Role in Glucose Control
Magnesium is an essential mineral that plays a critical role in glucose metabolism. It serves as a cofactor for numerous enzymes involved in glucose oxidation, insulin secretion, and cellular glucose uptake. Magnesium is also integral to maintaining normal energy metabolism and ensuring proper insulin-mediated glucose transport into cells.
Mechanism of Action
Magnesium modulates ATP generation, which is essential for glucose metabolism and insulin signaling. It is directly involved in the activation of the insulin receptor and downstream signaling pathways that facilitate glucose uptake by peripheral tissues. Low magnesium levels are associated with impaired insulin receptor activity and reduced glucose transport, worsening insulin resistance and glucose intolerance.
Evidence and Deficiency Implications
Epidemiological Studies: Observational studies have consistently demonstrated an association between low serum magnesium levels and an increased risk of Type 2 Diabetes Mellitus (T2DM).23,25 Magnesium deficiency has also been linked to poor glycemic control and an elevated risk of diabetes-related complications.24,27
Clinical Trials: Several interventional studies have shown that magnesium supplementation can improve glycemic markers such as fasting blood glucose and glycated hemoglobin (HbA1c). A meta-analysis of randomized controlled trials highlighted significant improvements in insulin sensitivity and glycemic control with magnesium supplementation, particularly in individuals with diabetes or prediabetes.25,26
Food Sources and RDI
Magnesium is found in leafy green vegetables, legumes, beans, and nuts. The Recommended Daily Intake for adults is 220-260 mg.
Therapeutic Dose and Safety
Depending on the form of magnesium used, doses greater than the tolerable upper intake level (UL) of 350 mg daily frequently cause loose stools and diarrhea. Bis-glycinate or glycinate forms tend to be better tolerated.
The most common adverse effects are diarrhea, gastrointestinal irritation, nausea, and vomiting.
With toxic doses, loss of reflexes and respiratory depression can occur. High doses in pregnancy are not recommended as they can increase the risk of neonatal mortality and neurological defects.
Zinc
Role in Insulin Synthesis and Function
Zinc is an essential trace element pivotal in insulin synthesis, storage, and secretion. It stabilizes insulin hexamers in pancreatic β-cells, facilitating efficient insulin storage and release.
Mechanism of Action
Zinc enhances insulin signaling by facilitating the phosphorylation of insulin receptors, which is crucial for initiating downstream signaling pathways that promote glucose uptake by cells.28 It also supports pancreatic β-cell function, helping to maintain glucose homeostasis. Zinc’s antioxidant properties help mitigate oxidative stress and inflammation, which are commonly elevated in individuals with diabetes.
Evidence and Deficiency Implications
Zinc Supplementation: Clinical trials and meta-analyses have reported improved glycemic markers, including reduced glycated hemoglobin (HbA1c) and fasting blood glucose levels, with zinc supplementation in diabetic patients.29,30, 32,33
Zinc Deficiency: Zinc deficiency is associated with increased oxidative stress and pro-inflammatory states, exacerbating insulin resistance and β-cell dysfunction. Observational studies have shown a higher prevalence of zinc deficiency in individuals with diabetes, further linking this micronutrient to glycemic regulation.31
Food Sources and RDI
Excellent food sources of zinc include oysters, which are among the richest natural sources, as well as red meat, poultry, and seafood like crab and lobster. Plant-based sources include legumes (such as chickpeas, lentils, and beans), nuts (like cashews and almonds), seeds (pumpkin and sunflower), and whole grains. However, the bioavailability of zinc from plant sources may be lower due to the presence of phytates, which can inhibit its absorption. The Recommended Dietary Intake (RDI) for adults is 11 mg per day for men and 8 mg per day for women, with increased needs during pregnancy (11 mg) and lactation (12 mg).
Therapeutic Dose and Safety
Zinc is likely safe when used orally and appropriately in doses higher than the tolerable upper intake level (UL) of 40 mg daily. Because the UL of zinc is based on regular daily intake, short-term ingestion above 40 mg daily is not likely to be harmful. There is some evidence that doses of elemental zinc as high as 80 mg daily in combination with 2 mg of copper can be used safely for approximately 6 years without significant adverse effects. However, there is some concern that doses higher than the UL of 40 mg daily might decrease copper absorption and result in anemia.
Testing for Mineral Status
While plasma mineral levels are valuable for assessing specific aspects of mineral status (e.g., hydration status, acute deficiencies or excesses), they do not always correlate well with tissue levels. This is particularly true for minerals like magnesium and zinc, where plasma levels are tightly regulated and may not reflect tissue levels or the body’s total stores.34
Conclusion
Recap of Key Micronutrients and Their Roles
This review underscores the critical roles of chromium, vanadium, vitamin B6, inositol, magnesium, and zinc in glucose metabolism. These nutrients act as cofactors for enzymatic processes, modulators of insulin signaling, and antioxidants combating oxidative stress. Evidence demonstrates that deficiencies in these micronutrients can impair glucose homeostasis, exacerbate insulin resistance, and contribute to the pathogenesis of Type 2 Diabetes Mellitus (T2DM) and its complications. When targeted and evidence-based, supplementation has shown promise in improving glycemic control.
Implications for Clinical Practice
Incorporating micronutrient assessment and management into clinical practice offers an evidence-based approach to improving outcomes for dysglycemic populations. Regular screening for deficiencies is critical, particularly in individuals with risk factors such as poor dietary intake, metabolic disorders, or chronic medication use. Targeted supplementation can complement traditional therapies, potentially reducing the need for higher pharmacological doses and mitigating complications.
Naturopathic Doctors should create comprehensive care plans that prioritize dietary quality, address deficiencies, and promote sustainable lifestyle changes. Micronutrient status is a cornerstone of effective weight and blood sugar management, contributing to better patient outcomes.
Since 1999, Dr. Pamela Frank has been practicing as a naturopathic doctor in Toronto, Canada. Dr. Pamela has a particular interest in assisting individuals with hormone-related concerns, such as PCOS, endometriosis, acne, hair loss, weight management, thyroid issues, and fertility. Other areas of interest include digestive issues, chronic, complex illness, and autoimmune disorders. Residing in Midtown Toronto with her family and lovable dog, Dolly, Dr. Pamela leads a fulfilling life outside work. You might catch her in the karate dojo, guiding a Scout Group, practicing yoga, camping, or immersing herself in various other pursuits that fulfill her adventurous spirit.
References
1. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629-636. doi:10.1161/ATVBAHA.107.151092.
2. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14(3):173-194. doi:10.2337/diacare.14.3.173.
3. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840-846. doi:10.1038/nature05482.
4. Petersen MC, Shulman GI. Mechanisms of Insulin Action and Insulin Resistance. Physiol Rev. 2018 Oct 1;98(4):2133-2223. doi: 10.1152/physrev.00063.2017.
5. McDonald, P. H., & Struthers, R. S. (2007). Signaling mechanisms involved in insulin resistance and the pathogenesis of type 2 diabetes. Journal of Clinical Investigation, 117(5), 1184-1194.
6. Bence, K. K., & Bence, N. F. (2012). Protein tyrosine phosphatases in insulin action and resistance. Current Opinion in Pharmacology, 12(5), 552-558.
7. Suksomboon N, Poolsup N, Yuwanakorn A. Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. J Clin Pharm Ther. 2014 Jun;39(3):292-306. doi: 10.1111/jcpt.12147. Epub 2014 Mar 17. PMID: 24635480.
8. Balk EM, Tatsioni A, Lichtenstein AH, Lau J, Pittas AG. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care. 2007 Aug;30(8):2154-63. doi: 10.2337/dc06-0996
9. Zhao F, Pan D, Wang N, Xia H, Zhang H, Wang S, Sun G. Effect of Chromium Supplementation on Blood Glucose and Lipid Levels in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-analysis. Biol Trace Elem Res. 2022 Feb;200(2):516-525. doi: 10.1007/s12011-021-02693-3.
10. Anderson RA. Chromium, glucose intolerance, and diabetes. J Am Coll Nutr. 1998;17(6):548-555. doi:10.1080/07315724.1998.10718801.
11. Zhao Y, Zhou M, Shang Y, Dou M, Gao S, Yang H, Zhang F. Effects of co-supplementation of chromium and magnesium on metabolic profiles, inflammation, and oxidative stress in impaired glucose tolerance. Diab Vasc Dis Res. 2024 Jan-Feb;21(1):14791641241228156. doi: 10.1177/14791641241228156. PMID: 38228168; PMCID: PMC10798099.
12. Alkhalidi F. A comparative study to assess the use of chromium in type 2 diabetes mellitus. J Med Life. 2023 Aug;16(8):1178-1182. doi: 10.25122/jml-2023-0081. PMID: 38024820; PMCID: PMC10652672.
13. Goldfine AB, Patti ME, Zuberi L, Goldstein BJ, LeBlanc R, Landaker EJ, Jiang ZY, Willsky GR, Kahn CR. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies. Metabolism. 2000 Mar;49(3):400-10. doi: 10.1016/s0026-0495(00)90418-9. PMID: 10726921.
14. Boden G, Chen X, Ruiz J, van Rossum GD, Turco S. Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism. 1996 Sep;45(9):1130-5. doi: 10.1016/s0026-0495(96)90013-x. PMID: 8781301.
15. Mascolo E, Vernì F. Vitamin B6 and Diabetes: Relationship and Molecular Mechanisms. Int J Mol Sci. 2020 May 23;21(10):3669. doi: 10.3390/ijms21103669. PMID: 32456137; PMCID: PMC7279184.
16. Hellmann H, Mooney S. Vitamin B6: A Molecule for Human Health? Molecules. 2010;15(1):442-459. doi:10.3390/molecules15010442.
17. Vernì F. Vitamin B6 and diabetes and its role in counteracting advanced glycation end products. Vitam Horm. 2024;125:401-438. doi: 10.1016/bs.vh.2024.02.005. Epub 2024 May 7. PMID: 38997171.
18. Bendich A, Cohen M. Vitamin B6 safety issues. Ann N Y Acad Sci 1990;585:321-30.
19. Schaumburg H, Kaplan J, Windebank A. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med 1983;309:445-8.
20. Pintaudi B, Di Vieste G, Bonomo M. The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes. Int J Endocrinol. 2016;2016:9132052. doi: 10.1155/2016/9132052. Epub 2016 Oct 11. PMID: 27807448; PMCID: PMC5078644.
21. Croze ML, Soulage CO. Potential Role and Therapeutic Interests of Myo-Inositol in Metabolic Diseases. Biochimie. 2013;95(10):1811-1827. doi:10.1016/j.biochi.2013.05.011.
22. Genazzani AD, Lanzoni C. Myo-Inositol in the Treatment of Insulin Resistance in PCOS. Eur Rev Med Pharmacol Sci. 2013;17(20):2735-2738.
23. Barbagallo M, Dominguez LJ. Magnesium and Type 2 Diabetes. World J Diabetes. 2015;6(10):1152-1157. doi:10.4239/wjd.v6.i10.1152.
24. Guerrero-Romero F, Tamez-Perez HE, González-González G, Salinas-Martínez AM, Montes-Villarreal J, Treviño-Ortiz JH, Rodríguez-Morán M. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab. 2004 Jun;30(3):253-8. doi: 10.1016/s1262-3636(07)70116-7. PMID: 15223977.
25. Dong JY, Xun P, He K, Qin LQ. Magnesium Intake and Risk of Type 2 Diabetes: Meta-Analysis of Prospective Cohort Studies. Diabetes Care. 2011;34(9):2116-2122. doi:10.2337/dc11-0518.
26. Fang X, Wang K, Han D, et al. Dietary Magnesium Intake and the Risk of Cardiovascular Disease, Type 2 Diabetes, and All-Cause Mortality: A Dose-Response Meta-Analysis of Prospective Cohort Studies. BMC Med. 2016;14:210. doi:10.1186/s12916-016-0742-z.
27. De Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in Man: Implications for Health and Disease. Physiol Rev. 2015;95(1):1-46. doi:10.1152/physrev.00012.2014.
28. Jayawardena R, Ranasinghe P, Galappatthy P, Malkanthi RL, Constantine GR, Katulanda P. Zinc and diabetes mellitus: understanding molecular mechanisms and clinical implications. Biol Trace Elem Res. 2012;150(3):321-336. doi:10.1007/s12011-012-9448-3.
29. Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr. 1998 Apr;17(2):109-15. doi: 10.1080/07315724.1998.10718735. PMID: 9550453.
30. Jayawardena R, Ranasinghe P, Galappatthy P, Malkanthi R, Constantine G, Katulanda P. Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2012 Apr 19;4(1):13. doi: 10.1186/1758-5996-4-13. PMID: 22515411; PMCID: PMC3407731.
31. Basaki M, Saeb M, Nazifi S, Shamsaei HA. Zinc, copper, iron, and chromium concentrations in young patients with type 2 diabetes mellitus. Biol Trace Elem Res. 2012 Aug;148(2):161-4. doi: 10.1007/s12011-012-9360-6. Epub 2012 Feb 21. PMID: 22351156.32.
32. Daneshvar, M., Ghaheri, M., Safarzadeh, D. et al. Effect of zinc supplementation on glycemic biomarkers: an umbrella of interventional meta-analyses. Diabetol Metab Syndr 16, 124 (2024). https://doi.org/10.1186/s13098-024-01366-0
33. Wang X, Wu W, Zheng W, Fang X, Chen L, Rink L, Min J, Wang F. Zinc supplementation improves glycemic control for diabetes prevention and management: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2019 Jul 1;110(1):76-90. doi: 10.1093/ajcn/nqz041. PMID: 31161192.
34. Rude, R K and Singer, F R, Magnesium Deficiency and Excess, Annual Review of Medicine, 1981, Volume 32, 245-259, https://doi.org/10.1146/annurev.me.32.020181.001333